Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4979255 | 1.00 | EPHX2 (0.38) | EPHX2GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL7495609 | 1.00 | EPHX2 (0.38) | EPHX2GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL5615748 | 0.95 | SLC1A2 (0.36) | EPHX2GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL6201855 | 0.81 | NOS3 (0.40) | EPHX2GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL28897083 | 0.80 | EPHX2 (0.41) | EPHX2ACE2GPR84FFAR1MAPT | |
| SCHEMBL9151091 | 0.79 | EPHX2 (0.43) | EPHX2ACE2GPR84FFAR1MAPT | |
| SCHEMBL9151095 | 0.79 | EPHX2 (0.43) | EPHX2ACE2GPR84FFAR1MAPT | |
| SCHEMBL20521900 | 0.78 | EPHX2 (0.43) | EPHX2GRIK1GRIK2ACE2GPR84 | |
| SCHEMBL11024188 | 0.77 | NOD1 (0.41) | EPHX2GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL8431794 | 0.76 | NOD1 (0.43) | EPHX2GRIK1GRIK2SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089107-A2 | NEAR-INFRARED ELECTROMAGNETIC MODIFICATION OF CELLULAR STEADY- STATE MEMBRANE POTENTIALS | Nomir Medical Technologies, Inc (US) | 2009-08-19 | — | — | EP | claimed |
| WO-2009082547-A1 | NEAR-INFRARED ELECTROMAGNETIC MODIFICATION OF CELLULAR STEADY-STATE MEMBRANE POTENTIALS | NOMIR MEDICAL TECHNOLOGIES, INC. (US) | 2009-07-02 | — | — | WO | claimed |
| WO-2008073979-A2 | NEAR-INFRARED ELECTROMAGNETIC MODIFICATION OF CELLULAR STEADY- STATE MEMBRANE POTENTIALS | NOMIR MEDICAL TECHNOLOGIES, INC. (US) | 2008-06-19 | — | — | WO | claimed |
| US-20080139992-A1 | Near-infrared electromagnetic modification of cellular steady-state membrane potentials | NOMIR MEDICAL TECHNOLOGIES, INC. (US) | 2008-06-12 | — | — | US | claimed |
| EP-3006038-B1 | SINGLE DOSES OF ORITAVANCIN FOR TREATING OR PREVENTING A BACTERIAL INFECTION | THE MEDICINES CO (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-4370664-A1 | LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES | Inbiose N.V. (BE) | 2024-05-22 | — | — | EP | disclosed |
| CN-117957316-A | Fucosyltransferase for converting lactose-N-disaccharide | 因比奥斯公司 | 2024-04-30 | — | — | CN | disclosed |
| EP-4347563-A1 | 2-CARBOXYL-INDOLE INHIBITORS OF METALLO-BETA-LACTAMASES | Oxford University Innovation Limited (GB) | 2024-04-10 | — | — | EP | disclosed |
| CN-116891852-A | Specific nucleic acid aptamer, targeted antibacterial drug-loaded gelatin microsphere modified by specific nucleic acid aptamer and application of targeted antibacterial drug-loaded gelatin microsphere | 四川大学 | 2023-10-17 | — | — | CN | disclosed |
| US-20230279403-A1 | PRODUCTION OF ALPHA-1,3 GLYCOSYLATED FORM OF FUC-A1,2-GAL-R | INBIOSE N.V. (BE) | 2023-09-07 | — | — | US | disclosed |
| WO-2023110994-A1 | PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS | INBIOSE N.V. (BE) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023110995-A1 | PRODUCTION OF ALPHA-1,3-FUCOSYLATED COMPOUNDS | INBIOSE N.V. (BE) | 2023-06-22 | — | — | WO | disclosed |
| US-5883074-A | Potentiators of antibacterial agents | MICROCIDE PHARMACEUTICALS, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| EP-0809708-A1 | POTENTIATORS OF ANTIBACTERIAL AGENTS | Microcide Pharmaceuticals, Inc. (US) | 1997-12-03 | — | — | EP | disclosed |
| WO-1996024684-A1 | POTENTIATORS OF ANTIBACTERIAL AGENTS | MICROCIDE PHARMACEUTICALS, INC. (US) | 1996-08-15 | — | — | WO | disclosed |
| CN-1012439-B | Method for producing antibiotic A40926 compound and pure factors PA.PB.A.B. and B. thereof | LEPETIT SPA (IT) | 1991-04-24 | — | — | CN | disclosed |
| US-4935238-A | Glycopeptidic substance; vancomycin class of antibiotics | GRUPPO LEPETIT, S.P.A. (IT) | 1990-06-19 | — | — | US | disclosed |
| US-4935238-A | Glycopeptidic substance; vancomycin class of antibiotics | GRUPPO LEPETIT, S.P.A. (IT) | 1990-06-19 | — | — | US | disclosed |
| EP-0177882-A2 | Antibiotic A 40926 complex and its pure factors PA, PB, A, B and BO | GRUPPO LEPETIT S.p.A. (IT) | 1986-04-16 | — | — | EP | disclosed |
| EP-0177882-A2 | Antibiotic A 40926 complex and its pure factors PA, PB, A, B and BO | GRUPPO LEPETIT S.p.A. (IT) | 1986-04-16 | — | — | EP | disclosed |